Lyfas is a Digital Biomarker, diagnostic and prognostic tool developed based on the principle of PhotoPlethysmoGraphy (PPG)
Basic Information
Bengaluru based Lyfas is a clinical grade mobile tool for clinicians that helps them to asses early risk of arrhythmia and endothelial dysfunction instantly from smartphone. It detects blood volume changes and reflected light spectrum of blood chemistry in the microvascular bed of tissue. Gathers vital functional biomarkers and parameters like pulse rate variability (PRV) reflecting heart rate variability (HRV), cardiac dynamics, conduction and stress, autonomic nervous function, vascular function and ageing, lung function and oxygen saturation, physicochemical properties of the blood to name a few. Digital Biomarkers tools like Lyfas enable both the clinician and patient to collect a longitudinal data, retrospectively process the collected data to forecast possible critical or relevant medical situations. Therefore, it can be used as a risk and event prediction tool for life threatening conditions like heart attacks and strokes.
Legal Name
:
Acculi Labs Pvt Ltd
Headquarters
:
Bangalore, Karnataka, India
Founding Date
:
2017
No. of Employees
:
11 to 20
Core Team
:
1.
Rupam Das
Founder & CEO
Funding
Investors
:
1.
Chandrashekar Kupperi
2.
Startup Basket
HealthTech / MedTech / Healthcare
HealthTech / MedTech / Healthcare
Recently Added Startups
Recently Added Startups
HealthTech / MedTech / Healthcare